Can Benign Leiomyoma Mimic Malignancy?
Yes, benign uterine leiomyomas can absolutely mimic malignancy on imaging and clinical presentation, particularly when they undergo degenerative changes, are large and pedunculated, or have specific histologic subtypes.
Key Clinical Scenarios Where Mimicry Occurs
Degenerative Changes Create Diagnostic Confusion
Large leiomyomas with extensive cystic or fatty degeneration frequently simulate malignant ovarian tumors or leiomyosarcomas on imaging studies 1, 2, 3. When subserosal pedunculated myomas undergo cystic degeneration, they can present as complex solid-cystic masses that are radiologically indistinguishable from ovarian malignancies 4, 3. The presence of bilateral cystic areas in a single pedunculated mass can even mimic bilateral ovarian cancer 3.
Specific Histologic Subtypes Are Particularly Deceptive
Cotyledonoid dissecting leiomyoma represents the most dramatic mimicker of malignancy, presenting as exophytic, multinodular masses with a congested, placenta-like appearance that protrudes over the uterine serosa and can extend to adjacent organs 5. Despite this alarming gross appearance and growth pattern, these tumors are entirely benign with no reported recurrences or metastases in follow-up periods ranging from 1 month to 41 years 5.
Lipoleiomyomas with extensive fatty and cystic degeneration can also simulate leiomyosarcoma or ovarian malignancy, particularly when they reach giant proportions 2.
Critical Imaging Features to Distinguish Benign from Malignant
MRI Characteristics
On MRI, benign leiomyomas—even those mimicking malignancy—are typically:
- Isointense to myometrium on T1-weighted images
- Less heterogeneous on T2 and post-contrast imaging compared to sarcomatous lesions 5
- May show extension to but not frank invasion of surrounding organs 5
The Pedicle Sign
Detecting continuity of an abdominal mass with the uterus via a pedicle on imaging, especially in the absence of ascites, strongly suggests pedunculated subserosal leiomyoma rather than malignancy 4. This finding is particularly valuable when the mass shows extensive degenerative changes.
When to Suspect Underlying Malignancy
The ACR guidelines emphasize that approximately 1 in 350 women undergoing hysterectomy or myomectomy for presumed fibroids is found to have an unsuspected uterine sarcoma 6. MRI after uterine artery embolization is specifically recommended to ensure adequate fibroid infarction and to exclude underlying leiomyosarcoma 6.
Mandatory Pre-procedural Workup
Before any fibroid treatment, patients must undergo 6:
- Full gynecologic evaluation including Pap smear
- Endometrial biopsy if menometrorrhagia is present
- Cross-sectional imaging (preferably MRI) to confirm diagnosis and exclude other pelvic pathology
Common Diagnostic Pitfalls
Giant pedunculated subserosal myomas occupying the entire abdominopelvic cavity are frequently misdiagnosed as ovarian malignancies preoperatively 1, 4
Cellular leiomyomas with solid and cystic components can be mistaken for malignant mixed tumors 1
Ultrasound features are nonspecific for distinguishing benign from malignant lesions, making MRI the preferred imaging modality 5
The presence of intravascular growth in cotyledonoid dissecting leiomyoma (present in 20% of cases) appears devoid of clinical significance and should not be interpreted as evidence of malignancy 5
Clinical Context Matters
In women of childbearing age presenting with a grossly distended abdomen without obvious pregnancy or malignancy, subserosal uterine leiomyoma should be the primary consideration 4. The association with cervical myomas further heightens this diagnosis 4.
Angioleiomyoma, though rare in the uterus, represents another benign mimicker that can be distinguished by characteristic contrast enhancement on imaging and specific microscopic features 7.